Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 16;25(16):8927.
doi: 10.3390/ijms25168927.

Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice

Affiliations

Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice

Shinya Yokoyama et al. Int J Mol Sci. .

Abstract

This study investigates novel short-lived long noncoding RNAs (lncRNAs) in mice with altered expression in metabolic dysfunction-associated steatotic liver (MASH) and liver fibrosis. LncRNAs share similarities with mRNAs in their transcription by RNA polymerase II, possession of a 5' cap structure, and presence of a polyA tail. We identified two lncRNAs, Kcnq1ot1 and Rmst, significantly decreased in both conditions. These lncRNAs showed dramatic expression changes in MASH livers induced by Western diets and CCl4, and in fibrotic livers induced by CCl4 alone. The decrease was more pronounced in liver fibrosis, suggesting their potential as biomarkers for disease progression. Our findings are consistent across different fibrosis models, indicating a crucial role for these lncRNAs in MASH and liver fibrosis in mice. With MASH becoming a global health issue and its progression to fibrosis associated with hepatocarcinogenesis and poor prognosis, understanding the underlying mechanisms is critical. This research contributes to elucidating lncRNA functions in murine liver diseases and provides a foundation for developing novel therapeutic strategies targeting lncRNAs in MASH and liver fibrosis, offering new avenues for potential therapeutic interventions.

Keywords: Kcnq1ot1; Rmst; hepatocellular carcinoma; lncRNAs; mouse liver.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Mouse model fed Western diet (WD) and treated by CCl4-induced metabolic dysfunction-associated steatotic liver, which develops metabolic dysfunction-associated steatohepatitis (MASH). Control mice are fed in a control diet (CD). Hematoxylin and eosin (H&E) staining of livers from (A; left) CD-fed and (B; left) WD-fed mice. Sirius Red staining of livers from (A; right) CD-fed and (B; right) WD-fed mice. Scale bar: 100 μm. Arrowheads: hepatocyte ballooning, Arrows: infiltration of inflammatory cells.
Figure 2
Figure 2
Carbon tetrachloride (CCl4) induced mouse model, which develops liver fibrosis. Control mice are fed in a control diet (CD) with no administration of CCl4. Hematoxylin and eosin (H&E) staining of livers from (A; left) control and (B; left) CCl4 injected mice. Sirius Red staining of livers from (A; right) control and (B; right) CCl4 injected mice. Scale bar: 100 μm. Arrows: infiltration of inflammatory cells.
Figure 3
Figure 3
Alterations in lncRNA expression levels in model mice. Expression levels of the indicated RNAs were determined by RT-qPCR. GAPDH was used for normalization. Values represent the mean ± SD obtained from two (A) and four (B) independent experiments (** p < 0.01, Student’s t-test). The Y-axis indicated that the expression levels of WD-fed mice were divided by those of CD-fed mice. Thus, zero indicated that the RNA was not detectable and one indicated that there was no change in expression levels compared to the CD-fed mice.

Similar articles

Cited by

References

    1. Muto H., Honda T., Tanaka T., Yokoyama S., Yamamoto K., Ito T., Imai N., Ishizu Y., Maeda K., Ishikawa T., et al. Proteomic analysis reveals changes in tight junctions in the small intestinal epithelium of mice fed a high-fat diet. Nutrients. 2023;15:1473. doi: 10.3390/nu15061473. - DOI - PMC - PubMed
    1. Younossi Z.M., Koenig A.B., Abdelatif D., Fazel Y., Henry L., Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. doi: 10.1002/hep.28431. - DOI - PubMed
    1. Ito T., Ishigami M., Zou B., Tanaka T., Takahashi H., Kurosaki M., Maeda M., Thin K.N., Tanaka K., Takahashi Y., et al. The epidemiology of NAFLD and lean NAFLD in Japan: A meta-analysis with individual and forecasting analysis, 1995–2040. Hepatol. Int. 2021;15:366–379. doi: 10.1007/s12072-021-10143-4. - DOI - PubMed
    1. Tateishi R., Uchino K., Fujiwara N., Takehara T., Okanoue T., Seike M., Yoshiji H., Yatsuhashi H., Shimizu M., Torimura T., et al. A Nationwide Survey on Non-B, Non-C Hepatocellular Carcinoma in Japan: 2011–2015 Update. J. Gastroenterol. 2019;54:367–376. doi: 10.1007/s00535-018-1532-5. - DOI - PMC - PubMed
    1. Yu J., Shen J., Sun T.T., Zhang X., Wong N. Obesity, insulin resistance, NASH and hepatocellular carcinoma. Semin. Cancer Biol. 2013;23:483–491. doi: 10.1016/j.semcancer.2013.07.003. - DOI - PubMed

MeSH terms

LinkOut - more resources